Adaptive Biotechnologies Corp (NASDAQ:ADPT) traded at $2.75 at close of the session on Monday, April 29, made an upward move of 5.77% on its previous day’s price.
Looking at the stock we see that its previous close was $2.60. In terms of its 52-week price range, ADPT has a high of $9.08 and a low of $2.28. The company’s stock has lost about -14.33% over that past 30 days.
Adaptive Biotechnologies Corp has a market cap of $399.00 million. Estimates by analysts give the company expected earnings per share (EPS) of -$0.34, with the EPS growth for the year raised at -$1.3 for 2024 and -$1.04 for next year. These figures represent 16.70% and 20.00% growth in EPS for the two years respectively.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $38.78 million, with a low of $34.8 million and a high of $42.2 million. The median projection represents growth squeezing down to 3.00% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2024 is expected to hit $175.82 million, or 3.30% up from figures reported last year.
On the other hand, looking at the outlook for the ADPT stock, short term indicators assign the stock an average of 50% Sell, while medium term indicators assign it an average of 100% Sell. Long term indicators on average place the stock in the category of 100% Sell.
Looking further, we note the current price level is 2.09% off its SMA20 and -15.26% from its 50-day simple moving average. The RSI (14) is pointing at 47.62 while the volatility over the past week is 7.54% and jumps to 8.78% over the past one month. The beta value is 1.27, while the average true range (ATR) is currently pointing at 0.24.
Coming back to Adaptive Biotechnologies Corp (NASDAQ:ADPT), we note that the average 3-month trading volume was 1.69 million. Current shares outstanding are 145.08 million.
The insiders hold 4.54% of the company’s shares while institutions hold 98.14%. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -43.88% down in year-to-date price movement.
